Skip to main content
Dryad

Time-lapse videos and snapshot images of mycobacterial cells alone or during infection under drug treatment

Data files

Apr 08, 2024 version files 101.11 GB

Abstract

Original approaches are needed to cope with drug-recalcitrant infections that threaten global health, including tuberculosis. Here, we implemented a drug-discovery strategy based on a customized microfluidic dynamic single-cell screening for pheno-tuning compounds (µDeSCRiPTor). Our strategy assesses dynamic phenotypic changes occurring at the level of single mycobacterial cells upon exposure to pheno-tuning compounds, via time-lapse microscopy. The goal was to identify compounds that synergize with existing anti-tubercular drugs, ultimately making the bacterial population more homogeneously susceptible to therapy. Among the four identified hits, we focused on M06, which shows promise for improving tuberculosis therapy.